Posted January 23, 2014

"Slimming" Supplements Found to Contain Drugs

On January 21, 2014, the FDA advised consumers not to buy or use weight loss supplements Dream Body Slimming Capsule and Magic Slim because they were found to contain sibutramine and/or phenolphthalein.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective."

Dream Body Slimming Capsule is sold in some retail stores and on various websites, including, It was found to contain sibutramine. (This product was also found to contain sibutramine in 2011.)

Magic Slim is sold in some retail stores and on various websites, including including It was found to contain sibutramine and phenolphthalein.

(See's Reviews of Weight Loss Supplements for tests of related products.)

Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

See Related Warnings:

FDA Warns Consumers Against Eighteen Weight Loss Products Containing Drugs

FDA Warns Consumers Of Weight Loss Supplement Containing Undeclared Drug

Weight Loss Supplement Recalled Due To Undeclared Drug

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

Rx Drugs Found in Weight Loss and Enhancement Supplements

Recall of "Slimming" Supplements Spiked with Drug

For more recalls and warnings, use the link below.